Cargando…

Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is a disease with an extremely poor prognosis that is characterized by a rich extracellular matrix (ECM). Tenascin-C (TNC) is a component of the ECM and plays a role in tumour progression. In this study, we reported that TNC is overexpressed in PDAC tissues an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Jun, Lu, Wenli, Du, Shaoxia, Guo, Zhongkui, Wang, Hui, Wei, Wei, Shen, Xiaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277647/ https://www.ncbi.nlm.nih.gov/pubmed/30519351 http://dx.doi.org/10.7150/jca.25926

Ejemplares similares

Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer
por: Cai, Jun, et al.
Publicado: (2017)

Exosomal Tenascin-c induces proliferation and invasion of pancreatic cancer cells by WNT signaling
por: Qian, Songying, et al.
Publicado: (2019)

Exosomal Tenascin-c Induces Proliferation and Invasion of Pancreatic Cancer Cells by WNT Signaling [Retraction]
Publicado: (2022)

The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function
por: Wang, Hui, et al.
Publicado: (2021)

MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling
por: Mziaut, Hassan, et al.
Publicado: (2019)

IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma
por: Zhang, Le, et al.
Publicado: (2019)

Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration
por: Zhou, Shen’ao, et al.
Publicado: (2020)

Correction to: IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma
por: Zhang, Le, et al.
Publicado: (2019)

Apolipoprotein E2 Promotes the Migration and Invasion of Pancreatic Cancer Cells via Activation of the ERK1/2 Signaling Pathway
por: Wang, Hui, et al.
Publicado: (2020)

Tenascin-C Expression in Equine Tendon-derived Cells During Proliferation and Migration
por: NEMOTO, Manabu, et al.
Publicado: (2013)

The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer
por: Xu, Yingqiang, et al.
Publicado: (2015)

The extracellular matrix molecule tenascin-C modulates cell cycle progression and motility of adult neural stem/progenitor cells from the subependymal zone
por: Schaberg, Elena, et al.
Publicado: (2022)

Lentivirus-mediated RIG-I knockdown relieves cell proliferation inhibition, cell cycle arrest and apoptosis in ATRA-induced NB4 cells via the AKT-FOXO3A signaling pathway in vitro
por: Chen, Lei, et al.
Publicado: (2017)

Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours.
por: Wilson, K. E., et al.
Publicado: (1996)

Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitro
por: BEN, QIWEN, et al.
Publicado: (2014)

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
por: Roy, Sanjit K, et al.
Publicado: (2010)

Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs
por: Shen, Chaoyong, et al.
Publicado: (2019)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway
por: Song, Hong-ming, et al.
Publicado: (2015)

Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
por: Kong, Xiangchen, et al.
Publicado: (2015)

Quercetin Preserves β-Cell Mass and Function in Fructose-Induced Hyperinsulinemia through Modulating Pancreatic Akt/FoxO1 Activation
por: Li, Jian-Mei, et al.
Publicado: (2013)

SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma
por: Zhu, Hejia, et al.
Publicado: (2020)

Overexpression or Silencing of FOXO3a Affects Proliferation of Endothelial Progenitor Cells and Expression of Cell Cycle Regulatory Proteins
por: Sang, Tiantian, et al.
Publicado: (2014)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation
por: Castro, María Victoria, et al.
Publicado: (2021)

HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1
por: Li, Fei, et al.
Publicado: (2021)

Effects of circFOXO3 on the Proliferation and Invasion of Liver Cancer Cells by Regulating PI3K/Akt Pathway
por: Liu, Siyu, et al.
Publicado: (2022)

Tenascin turns on the EGFR
por: Jegalian, Karin
Publicado: (2001)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
por: Du, William W., et al.
Publicado: (2016)

Human Carcinoma Cells Synthesize and Secrete Tenascin in vitro
por: Kawakatsu, Hisaaki, et al.
Publicado: (1992)

Inhibition of Miro1 disturbs mitophagy and pancreatic β-cell function interfering insulin release via IRS-Akt-Foxo1 in diabetes
por: Chen, Lingling, et al.
Publicado: (2017)

Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway
por: Paron, Igor, et al.
Publicado: (2011)

SNAPIN Regulates Cell Cycle Progression to Promote Pancreatic β Cell Growth
por: Jiang, Mengxue, et al.
Publicado: (2021)

Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
por: Webster, L., et al.
Publicado: (1998)

Baicalein ameliorates osteoporosis via AKT/FOXO1 signaling
por: Cai, Pan, et al.
Publicado: (2021)

PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis
por: He, Zhen, et al.
Publicado: (2023)

WT1‐interacting protein inhibits cell proliferation and tumorigenicity in non‐small‐cell lung cancer via the AKT/FOXO1 axis
por: Wu, Zhiqiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ebivhh7rj0gc2upmg7a63n0ka8